查看购物车
  • Traditional Chinese
  • English
  • Japanese
PCR市场（第8版）：qPCR、dPCR、单重和多重PCR市场预测－按应用、产品和地点划分－高阶主管和顾问的指南，客製化预测和分析（2026-2030年）
市场调查报告书
商品编码
2025435

PCR市场（第8版）：qPCR、dPCR、单重和多重PCR市场预测－按应用、产品和地点划分－高阶主管和顾问的指南，客製化预测和分析（2026-2030年）

PCR Markets 8th Edition. Forecasts for qPCR, dPCR, Singleplex & Multiplex Markets and by Application, Product and Place. With Executive and Consultant Guides, Including Customized Forecasting and Analysis. 2026 to 2030
出版日期: | 出版商: Howe Sound Research | 英文 510 Pages | 商品交期: 最快1-2个工作天内

价格

报告摘要：

新冠疫情巩固了PCR作为领先技术的地位，但如今，新兴市场和技术正在改变疾病的诊断方式。 PCR在其中扮演核心角色。探索这个新兴全球市场中的机会与挑战。

本报告预测了未来五年的市场规模，是唯一一份分别分析单重和多重检测市场的报告。 PCR技术已在市场上证明了其强大的实力，而下一代PCR技术——数位PCR——有望延续这一成功。它将有助于降低成本、改善治疗效果，甚至有助于对抗抗药性。即时检测（POC​​T）和分子诊断这两大趋势正在融合，但这究竟意味着什么？这份全面的报告将为您揭晓答案。

我们的研究能让您成为组织内的专家。订购这份全面的报告，即可充分利用我们调查团队的专业能力。信用卡付款后，报告将立即发送至您的邮箱。请仔细阅读所有许可选项。如果您希望升级到更全面的许可，您的订单金额将计入您现有的许可。本报告由我们撰写，我们将透过电话或电子邮件提供使用支援。一如既往，我们提供免费的支援和额外的特定数据。

如有需要，我们将以Excel格式提供所有报告资料。

利用最新数据，自信地做出投资决策和评估。

目录

第一章 市集指南

  • 情境分析
  • 高阶主管和行销负责人的指南
  • 投资分析师和管理顾问指南
  • 人工智慧的影响

第二章：引言与市场定义

  • 什么是PCR技术？
  • PCR检测和综合征检测
  • 市场定义
  • 调查方法
  • 展望：医疗保健和体外诊断产业

第三章：PCR-PCR技术指南

  • 概念
    • 方法
  • 目的
  • PCR检测－优点和缺点
  • 各种类型的PCR

第四章 行业概览

  • 参与企业充满活力的市场
    • 学术研究办公室
    • 诊断测试开发人员
    • 测量仪器供应商
    • 化学品/试剂供应商
    • 病理检测用品供应商
    • 独立临床实验室
    • 国家/地区公共研究机构
    • 医院检查室
    • 医师诊所检查室(POLS)
    • 审计机构
    • 认证机构

第五章 市场趋势

  • 成长驱动因素
  • 成长阻碍因素
  • 诊断技术发展

第六章：PCR的最新趋势

第七章 主要PCR公司概述

  • Abbott Laboratories
  • Accelerate Diagnostics
  • Ador Diagnostics
  • ADT Biotech
  • Agilent
  • Akonni Biosystems
  • Altona Diagnostics
  • Alveo Technologies
  • Amoy Diagnostics Co., Ltd.
  • Anatolia Geneworks
  • Applied BioCode
  • Applied DNA Sciences
  • Aurora Biomed
  • Aus Diagnostics
  • AVIVA Systems Biology
  • Beckman Coulter Diagnostics（Danaher）
  • Becton, Dickinson and Company
  • Binx Health
  • Biocartis
  • bioMerieux Diagnostics
  • Bioneer Corporation
  • Bio-Rad Laboratories, Inc
  • Bosch Healthcare Solutions GmbH
  • Bruker
  • Caris Molecular Diagnostics
  • Cepheid（Danaher）
  • Credo Diagnostics Biomedical
  • CTK Biotech
  • Cue Health
  • Curetis（OpGen）
  • Diagenode Diagnostics（Hologic）
  • Diasorin SpA
  • Eiken Chemical
  • Enzo Biochem
  • Eurofins Scientific
  • Fluxergy
  • Fujirebio
  • Genetic Signatures
  • GenMark Dx（Roche）
  • Greiner Bio-One
  • Hologic
  • Immunexpress
  • Inflammatix
  • Invetech
  • J&J Innovative Medicine
  • Karius
  • LumiraDx
  • Maxim Biomedical
  • Meridian Bioscience
  • Millipore Sigma
  • Molbio Diagnostics
  • Nanomix
  • NGeneBio
  • Noacyt
  • Nuclein
  • Operon
  • Panagene
  • Precipio
  • Primerdesign（Novacyt）
  • Promega
  • Prominex
  • Qiagen
  • QuantuMDx
  • QuidelOrtho
  • Randox Toxicology
  • R-Biopharm AG
  • Revvity
  • Roche Diagnostics
  • Scope Fluidics
  • SD Biosensor
  • Seegene
  • Siemens Healthineers
  • SkylineDx
  • Sona Nanotech
  • SpeeDx
  • Standard BioTools
  • Stilla Technologies
  • Streamline Scientific
  • T2 Biosystems
  • Thermo Fisher Scientific
  • Uniogen
  • Vela Diagnostics
  • Veramarx
  • Veredus Laboratories
  • Vircell
  • Visby Medical
  • XCR Diagnostics
  • YD Diagnostics
  • Zhejiang Orient Gene Biotech

第八章：全球PCR市场

  • PCR - 全球市场概览（按国家/地区划分）
  • 全球市场概览（按应用领域划分）
  • 全球市场概览（依技术划分）
  • 全球市场概览（按产品类别划分）
  • 区域全球市场概览

第九章：全球PCR市场－按应用领域划分

  • 临床多学科
  • 临床单例
  • 研究
  • 其他

第十章：全球PCR市场－依技术划分

  • qPCR
  • dPCR
  • 其他的

第十一章：全球PCR市场－依产品划分

  • PCR设备
  • PCR核酸萃取
  • PCR耗材
  • PCR服务

第十二章：全球PCR市场－按地区划分

  • 临床检查室
  • 照护现场
  • 商业的
  • 製药公司
  • 其他的

第十三章附录

Product Code: TECHPCR 426

Report Overview:

The pandemic drove PCR into a dominant technology role but now new markets and technologies are opening up that will change how diseases are diagnosed. PCR plays a central role. Find out about the opportunities and threats in this new global market.

The report forecasts the market size out five years with the only analysis available that breaks out Singleplex and Multiplex testing markets. PCR has proved itself in the market. And the new generation of PCR, digital PCR promises to keep that success going. Lowering costs, improving outcomes and even helping in the battle against Anti Microbial Resistance The two key trends of Point of Care Testing and Molecular Diagnostics are merging but what does that look like? Find out in this comprehensive report.

Our research makes you the expert in your organization. Get our research team working for you by ordering this comprehensive report. Your credit card order sends the report to your inbox instantly. Check all your licensing options but don't worry, your order is available as a credit if you wish to upgrade to a wider license. We wrote this report and we are ready, by phone or email, to help you use it. As always, assistance, and additional specific data, is provided without additional charges.

All report data is available in Excel format on request.

Make investment decisions and valuations with confidence using the latest data.

Table of Contents

1 Market Guides

  • 1.1 Situation Analysis
  • 1.2 Guide for Executives and Marketing Staff
  • 1.3 Guide for Investment Analysts and Management Consultants
  • 1.4 Impact of Artificial Intelligence

2 Introduction and Market Definition

  • 2.1 What are PCR Technologies?
  • 2.2 PCR and Syndromic Testing
  • 2.3 Market Definition
    • 2.3.1 Market Size
    • 2.3.2 Currency
    • 2.3.3 Years
  • 2.4 Methodology
    • 2.4.1 Methodology
    • 2.4.2 Sources
    • 2.4.3 Authors
  • 2.5 Perspective: Healthcare and the IVD Industry
    • 2.5.1 Global Healthcare Spending
    • 2.5.2 Spending on Diagnostics
    • 2.5.3 Important Role of Insurance for Diagnostics

3 PCR - Guide to PCR Technologies

  • 3.1 Concepts
    • 3.1.1 Method
  • 3.2 Applications
    • 3.2.1 Finding Specific DNA
    • 3.2.2 Measuring DNA
    • 3.2.3 Medical and Diagnostic Applications
      • 3.2.3.1 Carrier, prenatal and tissue typing
      • 3.2.3.2 Cancer Diagnosis and Management
      • 3.2.3.3 Infectious Disease - New Levels of Accuracy and Sensitivity
      • 3.2.3.4 Forensic Applications
      • 3.2.3.5 Science and Research
  • 3.3 PCR - Advantages and Disadvantages
  • 3.4 Different Types of PCR
    • 3.4.1 Simple Changes
      • 3.4.1.1 Multiplex-PCR
      • 3.4.1.2 VNTR PCR
      • 3.4.1.3 Asymmetric PCR
      • 3.4.1.4 Long PCR
      • 3.4.1.5 Nested PCR
      • 3.4.1.6 Quantitative PCR
      • 3.4.1.7 Hot-start PCR
      • 3.4.1.8 Touchdown PCR
      • 3.4.1.9 Assembly PCR
      • 3.4.1.10 Colony PCR
      • 3.4.1.11 Suicide PCR
      • 3.4.1.12 Cold PCR
    • 3.4.2 Digital PCR
      • 3.4.2.1 Droplet Digital PCR
      • 3.4.2.2 Comparison between dPCR and Real-Time PCR (qPCR)
      • 3.4.2.3 Digital PCR in Use
      • 3.4.2.4 Digital PCR Commercial History
    • 3.4.3 Isothermal PCR

4 Industry Overview

  • 4.1 Players in a Dynamic Market
    • 4.1.1 Academic Research Lab
    • 4.1.2 Diagnostic Test Developer
    • 4.1.3 Instrumentation Supplier
    • 4.1.4 Chemical/Reagent Supplier
    • 4.1.5 Pathology Supplier
    • 4.1.6 Independent Clinical Laboratory
    • 4.1.7 Public National/regional Laboratory
    • 4.1.8 Hospital Laboratory
    • 4.1.9 Physicians Office Lab (POLS)
    • 4.1.10 Audit Body
    • 4.1.11 Certification Body

5 Market Trends

  • 5.1 Factors Driving Growth
    • 5.1.1 A New Standard
    • 5.1.2 Down the Curve We Go
    • 5.1.3 Multiplexing
    • 5.1.4 Syndromic Diagnostics Looks Unstoppable
    • 5.1.5 The Genetic Blizzard
  • 5.2 Factors Limiting Growth
    • 5.2.1 The Cost Curve
    • 5.2.2 The Other Guys
    • 5.2.3 Systemic Roadblocks
  • 5.3 Diagnostic Technology Development
    • 5.3.1 The Instrumentation Curve
    • 5.3.2 Shifting Role of Diagnostics
    • 5.3.3 Diagnostics Moves Out of the Hospital
    • 5.3.4 Disruption Looms
    • 5.3.5 The Next Five Years

6 PCR Recent Developments

  • 6.1 Recent Developments - Importance and How to Use This Section
    • 6.1.1 Importance of These Developments
    • 6.1.2 How to Use This Section
  • 6.2 Bio-Rad to acquire Stilla Technologies
  • 6.3 OralDNA Labs Acquires Point-of-Care qPCR Tech
  • 6.4 Qiagen, Eli Lilly Collaborate on Alzheimer's Risk Dx Panel
  • 6.5 CARB-X Makes Awards to Prompt Diagnostics, Fuse Diagnostics for STI Tests
  • 6.6 Qiagen QiAcuity dPCR PanCancer Kits and QiaSeq Targeted RNA-seq Panel
  • 6.7 Seegene, Microsoft Collaborate for MDx Development
  • 6.8 QuidelOrtho Expanding Savanna Test Menu
  • 6.9 Binx Health Refocuses on POC STI Testing
  • 6.10 Qiagen, Myriad Genetics Partner to Develop Cancer Dx
  • 6.11 VedaBio Detecting Nucleic Acid With CRISPR
  • 6.12 Evvy Launches Add-on STI Screen
  • 6.13 ChromaCode Shifts to Oncology with dPCR Lung Cancer Test
  • 6.14 Multiplex Meningitis/Encephalitis Panel Market Expanding
  • 6.15 Sensible Dx to Launch 10-Minute POC PCR System
  • 6.16 ReadyGo Dx Plans to Make MDx Testing Easy
  • 6.17 Transformative Biotech Acquires Summit Biolabs' PCR Tech
  • 6.18 Visby Medical POC STI Multiplex Test Cleared
  • 6.19 Sherlock Biosciences Buys Sense Biodetection
  • 6.20 Agilent, Qiagen Nab FDA Approvals for Lung Cancer Treatment CDx
  • 6.21 HealthTrackRx Investing in Rapid Turnaround Times
  • 6.22 LEX Dx Developing Ultra-Fast Low-Cost PCR
  • 6.23 Next-Gen Dx Technologies Face Uncertain Future
  • 6.24 Rover Dx Developing All-Optical Rapid POC qPCR Platform
  • 6.25 ProtonDx Plans Rapid Molecular Dx Instrument
  • 6.26 Innova Medical Group Licenses MDx Tech
  • 6.27 MicroGEM to Grow Market for 30-Minute RT-PCR System
  • 6.28 Precipio Receives CE-IVD Mark for Cancer Panels
  • 6.29 Siemens Healthineers to Develop Next-Gen MDx Platform
  • 6.30 New York State Approves Enzo Biochem HPV Molecular Test
  • 6.31 Grip Molecular Developing Biosensor Panel to Detect Respiratory Infections
  • 6.32 Co-Diagnostics Seeks EUA for At-Home PCR Diagnostic System
  • 6.33 Chelex-Based Protocol to Reduce Cost, Time for PCR Testing
  • 6.34 Finnish Firms to Form Point-of-Care Testing Firm
  • 6.35 Visby Medical Scales Up Handheld PCR Test for STIs
  • 6.36 DnaNudge Raises $60M
  • 6.37 Roche Reports Diagnostics Revenue Up 51 Percent
  • 6.38 BforCure Preparing Multiple ID Panels for PoC qPCR Platform
  • 6.39 Enzo Biochem, CLX Health Partner for C19 Testing for Travel
  • 6.40 Bio Molecular Systems Gets Approval for Portable PCR Cycler
  • 6.41 Roche Acquires GenMark
  • 6.42 Handheld qPCR Devices Close to Commercialization
  • 6.43 Nuclein Closes $14M in Funding
  • 6.44 WuXi Diagnostics Closes $150M Series B Financing Round
  • 6.45 Visby Medical to develop rapid Flu-COVID PCR test
  • 6.46 Thermo Fisher to acquire Mesa Biotech

7 Profiles of Key PCR Companies

  • 7.1 Abbott Laboratories
  • 7.2 Accelerate Diagnostics
  • 7.3 Ador Diagnostics
  • 7.4 ADT Biotech
  • 7.5 Agilent
  • 7.6 Akonni Biosystems
  • 7.7 Altona Diagnostics
  • 7.8 Alveo Technologies
  • 7.9 Amoy Diagnostics Co., Ltd.
  • 7.10 Anatolia Geneworks
  • 7.11 Applied BioCode
  • 7.12 Applied DNA Sciences
  • 7.13 Aurora Biomed
  • 7.14 Aus Diagnostics
  • 7.15 AVIVA Systems Biology
  • 7.16 Beckman Coulter Diagnostics (Danaher)
  • 7.17 Becton, Dickinson and Company
  • 7.18 Binx Health
  • 7.19 Biocartis
  • 7.20 bioMerieux Diagnostics
  • 7.21 Bioneer Corporation
  • 7.22 Bio-Rad Laboratories, Inc
  • 7.23 Bosch Healthcare Solutions GmbH
  • 7.24 Bruker
  • 7.25 Caris Molecular Diagnostics
  • 7.26 Cepheid (Danaher)
  • 7.27 Credo Diagnostics Biomedical
  • 7.28 CTK Biotech
  • 7.29 Cue Health
  • 7.30 Curetis (OpGen)
  • 7.31 Diagenode Diagnostics (Hologic)
  • 7.32 Diasorin S.p.A.
  • 7.33 Eiken Chemical
  • 7.34 Enzo Biochem
  • 7.35 Eurofins Scientific
  • 7.36 Fluxergy
  • 7.37 Fujirebio
  • 7.38 Genetic Signatures
  • 7.39 GenMark Dx (Roche)
  • 7.40 Greiner Bio-One
  • 7.41 Hologic
  • 7.42 Immunexpress
  • 7.43 Inflammatix
  • 7.44 Invetech
  • 7.45 J&J Innovative Medicine
  • 7.46 Karius
  • 7.47 LumiraDx
  • 7.48 Maxim Biomedical
  • 7.49 Meridian Bioscience
  • 7.50 Millipore Sigma
  • 7.51 Molbio Diagnostics
  • 7.52 Nanomix
  • 7.53 NGeneBio
  • 7.54 Noacyt
  • 7.55 Nuclein
  • 7.56 Operon
  • 7.57 Panagene
  • 7.58 Precipio
  • 7.59 Primerdesign (Novacyt)
  • 7.60 Promega
  • 7.61 Prominex
  • 7.62 Qiagen
  • 7.63 QuantuMDx
  • 7.64 QuidelOrtho
  • 7.65 Randox Toxicology
  • 7.66 R-Biopharm AG
  • 7.67 Revvity
  • 7.68 Roche Diagnostics
  • 7.69 Scope Fluidics
  • 7.70 SD Biosensor
  • 7.71 Seegene
  • 7.72 Siemens Healthineers
  • 7.73 SkylineDx
  • 7.74 Sona Nanotech
  • 7.75 SpeeDx
  • 7.76 Standard BioTools
  • 7.77 Stilla Technologies
  • 7.78 Streamline Scientific
  • 7.79 T2 Biosystems
  • 7.80 Thermo Fisher Scientific
  • 7.81 Uniogen
  • 7.82 Vela Diagnostics
  • 7.83 Veramarx
  • 7.84 Veredus Laboratories
  • 7.85 Vircell
  • 7.86 Visby Medical
  • 7.87 XCR Diagnostics
  • 7.88 YD Diagnostics
  • 7.89 Zhejiang Orient Gene Biotech

8 The Global PCR Markets

  • 8.1 PCR - Global Market Overview by Country
    • 8.1.1 Table - Global Market by Country
    • 8.1.2 Chart - Global Market by Country
  • 8.2 Global Market by Application - Overview
    • 8.2.1 Table - Global Market by Application
    • 8.2.2 Chart - Global Market by Application - Segments Growth
    • 8.2.3 Chart - Global Market by Application - Base/Final Comparison
    • 8.2.4 Chart - Global Market by Application - Base Year
    • 8.2.5 Chart - Global Market by Application - Final Year
    • 8.2.6 Chart - Global Market by Application - Share by Year
  • 8.3 Global Market by Technology - Overview
    • 8.3.1 Table - Global Market by Technology
    • 8.3.2 Chart - Global Market by Technology - Segments Growth
    • 8.3.3 Chart - Global Market by Technology - Base/Final Comparison
    • 8.3.4 Chart - Global Market by Technology - Base Year
    • 8.3.5 Chart - Global Market by Technology - Final Year
    • 8.3.6 Chart - Global Market by Technology - Share by Year
  • 8.4 Global Market by Product - Overview
    • 8.4.1 Table - Global Market by Product
    • 8.4.2 Chart - Global Market by Product - Segments Growth
    • 8.4.3 Chart - Global Market by Product - Base/Final Comparison
    • 8.4.4 Chart - Global Market by Product - Base Year
    • 8.4.5 Chart - Global Market by Product - Final Year
    • 8.4.6 Chart - Global Market by Product - Share by Year
  • 8.5 Global Market by Place - Overview
    • 8.5.1 Table - Global Market by Place
    • 8.5.2 Chart - Global Market by Place - Segments Growth
    • 8.5.3 Chart - Global Market by Place - Base/Final Comparison
    • 8.5.4 Chart - Global Market by Place - Base Year
    • 8.5.5 Chart - Global Market by Place - Final Year
    • 8.5.6 Chart - Global Market by Place - Share by Year

9 Global PCR Markets - By Application

  • 9.1 PCR Clinical Multiplex
    • 9.1.1 Table PCR Clinical Multiplex Testing - by Country
    • 9.1.2 Chart - PCR Clinical Multiplex Testing Growth
  • 9.2 PCR Clinical Singleplex
    • 9.2.1 Table PCR Clinical Singleplex Testing - by Country
    • 9.2.2 Chart - PCR Clinical Singleplex Testing Growth
  • 9.3 PCR Research
    • 9.3.1 Table PCR Research - by Country
    • 9.3.2 Chart - PCR Research Growth
  • 9.4 PCR Other Application
    • 9.4.1 Table PCR Other Application - by Country
    • 9.4.2 Chart - Other Application Growth

10 Global PCR Markets - By Technology

  • 10.1 qPCR
    • 10.1.1 Table qPCR - by Country
    • 10.1.2 Chart - qPCR Growth
  • 10.2 dPCR
    • 10.2.1 Table dPCR - by Country
    • 10.2.2 Chart - dPCR Growth
  • 10.3 Other Technology
    • 10.3.1 Table Other Technology - by Country
    • 10.3.2 Chart - Other Technology Growth

11 Global PCR Markets - By Product

  • 11.1 PCR Instruments
    • 11.1.1 Table PCR Instruments - by Country
    • 11.1.2 Chart - PCR Instruments Growth
  • 11.2 PCR Nucleic Acid Extraction
    • 11.2.1 Table PCR Nucleic Acid Extraction - by Country
    • 11.2.2 Chart - PCR Nucleic Acid Extraction Growth
  • 11.3 PCR Consumables
    • 11.3.1 Table PCR Consumables - by Country
    • 11.3.2 Chart - PCR Consumables Growth
  • 11.4 PCR Services
    • 11.4.1 Table Services - by Country
    • 11.4.2 Chart - PCR Services Growth

12 Global PCR Markets - By Place

  • 12.1 PCR Clinical Laboratory
    • 12.1.1 Table PCR Clinical Clinical Laboratory - by Country
    • 12.1.2 Chart - PCR Clinical Clinical Laboratory Growth
  • 12.2 PCR Point of Care
    • 12.2.1 Table PCR Point of Care - by Country
    • 12.2.2 Chart - PCR Point of Care Growth
  • 12.3 PCR Commercial
    • 12.3.1 Table PCR Commercial - by Country
    • 12.3.2 Chart - PCR Commercial Growth
  • 12.4 PCR Pharmaceutical
    • 12.4.1 Table PCR Pharmaceutical - by Country
    • 12.4.2 Chart - PCR Pharmaceutical Growth
  • 12.5 PCR Other Place
    • 12.5.1 Table PCR Other Place - by Country
    • 12.5.2 Chart - PCR Other Place Growth

13 Appendices

  • 13.1 Growth of Approved IVD Test Menu
  • 13.2 Growth of Approved Average IVD Test Fee
  • 13.3 The Most Used IVD Assays
  • 13.4 The Highest Grossing Assays
  • 13.5 Laboratory Fees Schedule

Table of Tables

  • Table 1 Market Players by Type
  • Table 2 Five Factors Driving Growth
  • Table 3 Three Factors Limiting Growth
  • Table 4 Market Size by Country
  • Table 5 Global Market by Application
  • Table 6 Global Market by Technology
  • Table 7 Global Market by Product
  • Table 8 Global Market by Place
  • Table 9 PCR Clinical Multiplex by Country
  • Table 10 PCR Clinical Singleplex by Country
  • Table 11 PCR Research by Country
  • Table 12 PCR Other Application by Country
  • Table 13 qPCR by Country
  • Table 14 Other Technology by Country
  • Table 15 PCR Instruments by Country
  • Table 16 PCR Nucleic Acid Extraction by Country
  • Table 17 PCR Consumables by Country
  • Table 18 PCR Services by Country
  • Table 19 PCR Clinical Clinical Laboratory by Country
  • Table 20 PCR Point of Care by Country
  • Table 21 PCR Commercial by Country
  • Table 22 PCR Pharmaceutical by Country
  • Table 23 PCR Other Place by Country
  • Table 24 The Most Common Assays
  • Table 25 Largest Revenue Assays
  • Table 26 Clinical Lab Fee Schedule

Table of Figures

  • Figure 1 The Global Healthcare Market
  • Figure 2 the Lab Test Pie
  • Figure 3 The PCR Process
  • Figure 4 Creation of Sample Droplets for Digital PCR
  • Figure 5 The Road to Diagnostics
  • Figure 6 Comparing Syndromic and Targeted Testing
  • Figure 7 Comparing The New Diagnostics and Traditional Testing
  • Figure 8 Growth rates of PCR Diagnostic Segments
  • Figure 9 Base year Global Market Share Chart
  • Figure 10 PCR Market by Application - Segments Growth
  • Figure 11 PCR Market by Application - Base vs. final
  • Figure 12 PCR Market Base year
  • Figure 13 PCR Market Final Year
  • Figure 14 Application Share by Year
  • Figure 15 PCR Market by Technology - Segments Growth
  • Figure 16 PCR Market by Technology - Base vs. final
  • Figure 17 PCR Market by Technology Base year
  • Figure 18 PCR Market by Technology Final Year
  • Figure 19 Technology Share by Year
  • Figure 20 PCR Market by Product - Segments Growth
  • Figure 21 PCR Market by Product - Base vs. final
  • Figure 22 PCR Market by Product Base year
  • Figure 23 PCR Market by Product Final Year
  • Figure 24 Product Share by Year
  • Figure 25 PCR Market by Place - Segments Growth
  • Figure 26 PCR Market by Place - Base vs. final
  • Figure 27 PCR Market by Place Base year
  • Figure 28 PCR Market by Place Final Year
  • Figure 29 Place Share by Year
  • Figure 30 PCR Clinical Multiplex Testing Growth
  • Figure 31 PCR Clinical Singleplex Testing Growth
  • Figure 32 PCR Research Growth
  • Figure 33 PCR Other Application Growth
  • Figure 34 qPCR Growth
  • Figure 35 dPCR Growth
  • Figure 36 Other Technology Growth
  • Figure 37 PCR Instruments Growth
  • Figure 38 PCR Nucleic Acid Extraction Growth
  • Figure 39 PCR Consumables Growth
  • Figure 40 PCR Services Growth
  • Figure 41 PCR Clinical Clinical Laboratory Growth
  • Figure 42 PCR Point of Care Growth
  • Figure 43 PCR Commercial Growth
  • Figure 44 PCR Pharmaceutical Growth
  • Figure 45 PCR Other Place Growth
  • Figure 46 IVD Test Menu Growth
  • Figure 47 IVD Test Average Fees - A Ten Year View